Jack’s work largely focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences arena. He has particular experience conducting oral proceedings, having acted as an advocate before the EPO’s Boards of Appeal, Opposition Divisions and Examining Divisions. Aside from his EPO work, Jack is also practiced in drafting and managing the prosecution of global patent families. His work is focused on the biotechnology field, and Jack has significant experience with antibody therapeutics, vaccines, recombinant cell lines, bacteriophage therapies, engineered enzymes, stem and progenitor cell-based therapies and drug re-profiling.
Jack joined Carpmaels & Ransford in 2017, after training at another London-based firm of patent attorneys. He graduated from The University of Bath in 2012 with a first class Masters degree in Biochemistry, in which his final year research project involved the structural analysis of complement protein analogues in the malaria mosquito.
During his time as an undergraduate, Jack also completed two industrial placements at GlaxoSmithKline in the Department of Safety Assessment. His projects involved the development of an assay for detecting cardiotoxicity of lead compounds using human induced pluripotent stem cell-derived cardiomyocytes, and the metabolic profiling of hepatic transporter knockout mouse models using liquid chromatography-mass spectrometry.
In his spare time, Jack enjoys travel and attempting the occasional marathon.
- Certificate in IP Law
- Chartered Patent Attorney
- European Patent Attorney